145 related articles for article (PubMed ID: 38289485)
1. Findings in magnetic resonance imaging for restaging locally advanced rectal cancer.
Marjasuo S; Koskenvuo L; Lepistö A
Int J Colorectal Dis; 2024 Jan; 39(1):23. PubMed ID: 38289485
[TBL] [Abstract][Full Text] [Related]
2. Stepwise neoadjuvant chemoradiotherapy in the management of mid-low locally advanced rectal cancer.
Zhang YX; Liu HY; Jiang B; Wang WY; Wang HB; Lu YJ
Eur J Surg Oncol; 2020 Mar; 46(3):410-414. PubMed ID: 31627933
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
4. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.
Battersby NJ; Dattani M; Rao S; Cunningham D; Tait D; Adams R; Moran BJ; Khakoo S; Tekkis P; Rasheed S; Mirnezami A; Quirke P; West NP; Nagtegaal I; Chong I; Sadanandam A; Valeri N; Thomas K; Frost M; Brown G
Trials; 2017 Aug; 18(1):394. PubMed ID: 28851403
[TBL] [Abstract][Full Text] [Related]
5. The effect of neoadjuvant short-course radiotherapy and delayed surgery versus chemoradiation on postoperative outcomes in locally advanced rectal cancer patients - A propensity score matched nationwide audit-based study.
Hoendervangers S; Sparreboom CL; Intven MPW; Lange JF; Verkooijen HM; Doornebosch PG; van Grevenstein WMU;
Eur J Surg Oncol; 2020 Sep; 46(9):1605-1612. PubMed ID: 32192792
[TBL] [Abstract][Full Text] [Related]
6. MRI response rate after short-course radiotherapy on rectal cancer in the elderly comorbid patient: results from a retrospective cohort study.
Koëter T; van Elderen SGC; van Tilborg GFAJB; de Wilt JHW; Wasowicz DK; Rozema T; Zimmerman DDE
Radiat Oncol; 2020 Mar; 15(1):53. PubMed ID: 32122381
[TBL] [Abstract][Full Text] [Related]
7. Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy.
Koëter T; Stijns RCH; van Koeverden S; Hugen N; van der Heijden JAG; Nederend J; van Zwam PH; Nagtegaal ID; Verheij M; Rutten HJT; de Wilt JHW
Colorectal Dis; 2021 Sep; 23(9):2341-2347. PubMed ID: 34051043
[TBL] [Abstract][Full Text] [Related]
8. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.
Sclafani F; Brown G; Cunningham D; Wotherspoon A; Tait D; Peckitt C; Evans J; Yu S; Sena Teixeira Mendes L; Tabernero J; Glimelius B; Cervantes A; Thomas J; Begum R; Oates J; Chau I
Ann Oncol; 2016 Aug; 27(8):1557-65. PubMed ID: 27217542
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
[No Abstract] [Full Text] [Related]
10. Magnetic resonance imaging tumor response score (mrTRS) predicts therapeutic effect and prognosis of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A prospective, multi-center study.
Guan Z; Sun RJ; Cao WT; Zhang HM; Yu T; Yu XP; Zhang JX; Zhang XY; Li XT; Zhou ZY; Zhao XM; Wen L; Sun YS
Radiother Oncol; 2020 Oct; 151():288-295. PubMed ID: 32890612
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
Liao CK; Kuo YT; Lin YC; Chern YJ; Hsu YJ; Yu YL; Chiang JM; Hsieh PS; Yeh CY; You JF
Curr Oncol; 2022 May; 29(5):3708-3727. PubMed ID: 35621687
[TBL] [Abstract][Full Text] [Related]
12. The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Liu GC; Zhang X; Xie E; An X; Cai PQ; Zhu Y; Tang JH; Kong LH; Lin JZ; Pan ZZ; Ding PR
Medicine (Baltimore); 2015 Nov; 94(47):e2074. PubMed ID: 26632714
[TBL] [Abstract][Full Text] [Related]
13. Short course radiotherapy and delayed surgery for locally advanced rectal cancer in frail patients: is it a valid option?
Lancellotti F; Solinas L; Sagnotta A; Mancini S; Cosentino LPM; Belardi A; Battaglia B; Mirri MA; Ciabattoni A; Salerno F; Loponte M
Eur J Surg Oncol; 2021 Aug; 47(8):2046-2052. PubMed ID: 33757649
[TBL] [Abstract][Full Text] [Related]
14. Preoperative concurrent chemoradiotherapy MRI characteristics favouring pathologic complete response in patients with rectal cancer: Usefulness of MR T2-stage as an ancillary finding for predicting pathologic complete response.
Lee HJ; Chung WS; An JH; Kim JH
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):166-174. PubMed ID: 33319450
[TBL] [Abstract][Full Text] [Related]
15. Current Practice Patterns in Locally Advanced Rectal Cancer at Academic Institutions: A National Survey Among Radiation Oncologists, Medical Oncologists, and Colorectal Surgeons.
Wu TC; Sanford NN; Anand S; Chu FI; Wo JY; Raldow AC
Clin Colorectal Cancer; 2022 Dec; 21(4):309-314. PubMed ID: 36216758
[TBL] [Abstract][Full Text] [Related]
16. Modest agreement between magnetic resonance and pathological tumor regression after neoadjuvant therapy for rectal cancer in the real world.
Achilli P; Magistro C; Abd El Aziz MA; Calini G; Bertoglio CL; Ferrari G; Mari G; Maggioni D; Peros G; Tamburello S; Coppola E; Spinelli A; Grass F; Martin D; Hahnloser D; Salvatori A; De Simoni S; Sheedy SP; Fletcher JG; Larson DW
Int J Cancer; 2022 Jul; 151(1):120-127. PubMed ID: 35191540
[TBL] [Abstract][Full Text] [Related]
17. The role of MRI after neochemoradiotherapy in predicting pathological tumor regression grade and clinical outcome in patients with locally advanced rectal adenocarcinoma.
Niu S; Chen Y; Peng F; Wen J; Xiong J; Yang Z; Peng J; Bao Y; Ding L
Front Oncol; 2023; 13():1118518. PubMed ID: 37377906
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study.
Hodges N; Battersby N; Rao S; Brown G;
Ann Surg Oncol; 2023 Aug; 30(8):4729-4735. PubMed ID: 35771366
[TBL] [Abstract][Full Text] [Related]
19. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
20. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]